price
DM
NASDAQ · DMAC
DiaMedica Therapeutics Inc.
Healthcare · Biotechnology
$6.85
Up+$0.00 (+0.00%)
Updated Sep 19, 2026, 1:46 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 486.92M
- P/E ratio
- -13.58
- Dividend yield
- 0.00%
- 52-week range
- $5.25 – $8.53
- Volume
- 194.96K
- Avg. volume
- 389.45K
Price performance
DMAC price history
1M range · 20 trading sessions · Daily adjusted prices
DMAC closed at $6.85 after 20 trading sessions, up 5.06% for the selected period.
- Last close
- $6.85
- Period change
- +5.06%
- Period low
- $6.35
- Period high
- $6.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $6.85 | $6.94 | $6.755 | $6.85 | 194.96K |
| Sep 17, 2026 | $6.75 | $7.00 | $6.675 | $6.85 | 257.77K |
| Sep 16, 2026 | $6.55 | $6.74 | $6.46 | $6.63 | 187.27K |
| Sep 15, 2026 | $6.55 | $6.65 | $6.36 | $6.53 | 157.94K |
| Sep 14, 2026 | $6.49 | $6.65 | $6.44 | $6.55 | 145.61K |
| Sep 11, 2026 | $6.57 | $6.877 | $6.33 | $6.47 | 123.61K |
| Sep 10, 2026 | $6.57 | $6.665 | $6.30 | $6.47 | 182.44K |
| Sep 9, 2026 | $6.50 | $6.9743 | $6.50 | $6.59 | 167.13K |
| Sep 8, 2026 | $6.70 | $6.71 | $6.53 | $6.54 | 119.06K |
| Sep 4, 2026 | $6.56 | $6.8873 | $6.49 | $6.75 | 189.48K |
| Sep 3, 2026 | $6.78 | $6.79 | $6.525 | $6.56 | 116.14K |
| Sep 2, 2026 | $6.60 | $6.9353 | $6.59 | $6.75 | 175.98K |
| Sep 1, 2026 | $6.29 | $6.45 | $6.265 | $6.45 | 145.93K |
| Aug 31, 2026 | $6.44 | $6.59 | $6.22 | $6.35 | 135.12K |
| Aug 28, 2026 | $6.72 | $6.74 | $6.34 | $6.39 | 116.51K |
| Aug 27, 2026 | $6.68 | $6.80 | $6.56 | $6.75 | 113.81K |
| Aug 26, 2026 | $6.66 | $6.76 | $6.62 | $6.70 | 118.27K |
| Aug 25, 2026 | $6.60 | $6.865 | $6.60 | $6.74 | 130.95K |
| Aug 24, 2026 | $6.53 | $6.57 | $6.32 | $6.52 | 85.66K |
| Aug 21, 2026 | $6.58 | $6.73 | $6.50 | $6.52 | 77.58K |
Latest DMAC news
The latest Smart Investors Daily articles mentioning DMAC.
Stock researchResearch & News · Analysis
Loading stock research…

